Market News
Recent Developments
- On October 25, 2023, Cadence Molecular Sciences (OpenEye), a business unit of Cadence Design Systems, announced that Pfizer Inc., an American multinational pharmaceutical and biotechnology corporation has signed an agreement to extend and expand access to Cadence products and programming toolkits for advanced molecular design.
- In January 2022, Discngine, a research and lab informatics software and services company, announced a strategic partnership with ChemAxon, a leading cheminformatics and bioinformatics company. By joining forces, partners expect to streamline pharma and biotech research involving complex biomolecular structural data.
- In October 2020, Dotmatics Ltd, a scientific informatics software and services company, announced it had expanded its product portfolio to include Blueprint, a self-service, scientific visualization and analytics application for small molecule discovery.
- In September 2020, Simulations Plus, Inc., the leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, announced that it had entered into an accelerated second phase of its collaboration with a large pharmaceutical company to tailor its high-throughput pharmacokinetic (HTPK) simulation functionality within ADMET Predictor to support the sponsor partner’s lead selection activities for small molecule programs.
Acquisition and Partnerships
- In September 2022, Cadence Design Systems, Inc. completed the acquisition of OpenEye Scientific Software, Inc. Adding OpenEye’s technologies and experienced team accelerates the Cadence Intelligent System Design strategy. It is done by extending Cadence’s computational software core competency to molecular modeling and simulation targeted at life sciences.
- In June 2022, TetraScience, the R&D Data Cloud, stated that ChemAxon, one of the leading web-based cheminformatics and bioinformatics software providers, joined the Tetra Partner Network. It is to help customers dramatically increase their capacity to find and synthesize chemical compounds with improved property profiles.